Neuroprotection in the Newborn Infant

Clinics in Perinatology

Volumn 36, Issue 4, 2009, Pages 859-880

  Gonzalez, Fernando F ^a,b   Ferriero, Donna M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hypoxia; Ischemia; Neonatal stroke; Neurogenesis; Neuroprotection

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 3 AMINOBENZAMIDE; ACETYLCYSTEINE; ALLOPURINOL; ALPHA TOCOPHEROL; AMPA RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE 3 INHIBITOR; DEFEROXAMINE; DIZOCILPINE; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; ESTRADIOL; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 6; KAINIC ACID RECEPTOR; M 826; MAGNESIUM SULFATE; MDL 28710; MELATONIN; MEMANTINE; MINOCYCLINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NITRIC OXIDE; SOMATOMEDIN C; TOPIRAMATE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; XENON;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BRAIN HEMORRHAGE; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; CLINICAL TRIAL; COGNITIVE DEFECT; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG PENETRATION; DRUG SAFETY; DRUG TARGETING; ENCEPHALOMALACIA; EXCITOTOXICITY; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; HYPOTENSION; INDUCED HYPOTHERMIA; INFLAMMATION; LEARNING DISORDER; LOW DRUG DOSE; MEMORY DISORDER; NEURAL STEM CELL TRANSPLANTATION; NEUROPROTECTION; NEWBORN PERIOD; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SINGLE DRUG DOSE; THERAPY EFFECT; TRANSIENT ISCHEMIC ATTACK;

ANTIOXIDANTS; BRAIN INJURIES; HUMANS; HYPOTHERMIA, INDUCED; INFANT, NEWBORN; NEUROGENESIS; NEUROPROTECTIVE AGENTS; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 70450200545     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2009.07.013     Document Type: Review

References (216)

1. Wu Y.W., Backstrand K.H., Zhao S., et al. Declining diagnosis of birth asphyxia in California: 1991-2000. Pediatrics 114 6 (2004) 1584-1590
2. Nelson K.B., and Lynch J.K. Stroke in newborn infants. Lancet Neurol 3 3 (2004) 150-158
3. Gressens P., and Luton D. Fetal MRI: obstetrical and neurological perspectives. Pediatr Radiol 34 9 (2004) 682-684
4. Miller S.P., McQuillen P.S., Hamrick S., et al. Abnormal brain development in newborns with congenital heart disease. N Engl J Med 357 19 (2007) 1928-1938
5. Dilenge M.E., Majnemer A., Shevell M.I., et al. Long-term developmental outcome of asphyxiated term neonates. J Child Neurol 16 11 (2001) 781-792
6. Ferriero D.M. Neonatal brain injury. N Engl J Med 351 19 (2004) 1985-1995
7. McQuillen P.S., and Ferriero D.M. Selective vulnerability in the developing central nervous system. Pediatr Neurol 30 4 (2004) 227-235
8. Geddes R., Vannucci R.C., Vannucci S.J., et al. Delayed cerebral atrophy following moderate hypoxia-ischemia in the immature rat. Dev Neurosci 23 3 (2001) 180-185
9. Gluckman P.D., Wyatt J.S., Azzopardi D., et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 365 9460 (2005) 663-670
10. Miller S.P., Latal B., Clark H., et al. Clinical signs predict 30-month neurodevelopmental outcome after neonatal encephalopathy. Am J Obstet Gynecol 190 1 (2004) 93-99
11. Hellstrom-Westas L., and Rosen I. Continuous brain-function monitoring: state of the art in clinical practice. Semin Fetal Neonatal Med 11 6 (2006) 503-511
12. Shellhaas R.A., Soaita A.I., Clancy R.R., et al. Sensitivity of amplitude-integrated electroencephalography for neonatal seizure detection. Pediatrics 120 4 (2007) 770-777
13. Chau V., Clement J.F., Robitaille Y., et al. Congenital axonal neuropathy and encephalopathy. Pediatr Neurol 38 4 (2008) 261-266
14. Miller S.P., Ramaswamy V., Michelson D., et al. Patterns of brain injury in term neonatal encephalopathy. J Pediatr 146 4 (2005) 453-460
15. Laptook A.R., Corbett R.J., Sterett R., et al. Modest hypothermia provides partial neuroprotection for ischemic neonatal brain. Pediatr Res 35 4 Pt 1 (1994) 436-442
16. Laptook A.R., Corbett R.J., Sterett R., et al. Modest hypothermia provides partial neuroprotection when used for immediate resuscitation after brain ischemia. Pediatr Res 42 1 (1997) 17-23
17. Thoresen M., Penrice J., Lorek A., et al. Mild hypothermia after severe transient hypoxia-ischemia ameliorates delayed cerebral energy failure in the newborn piglet. Pediatr Res 37 5 (1995) 667-670
18. Gunn A.J., Gunn T.R., de Haan H.H., et al. Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs. J Clin Invest 99 2 (1997) 248-256
19. Gunn A.J., Gunn T.R., Gunning M.I., et al. Neuroprotection with prolonged head cooling started before postischemic seizures in fetal sheep. Pediatrics 102 5 (1998) 1098-1106
20. Towfighi J., Housman C., Heitjan D.F., et al. The effect of focal cerebral cooling on perinatal hypoxic-ischemic brain damage. Acta Neuropathol 87 6 (1994) 598-604
21. Laptook A.R., and Corbett R.J. The effects of temperature on hypoxic-ischemic brain injury. Clin Perinatol 29 4 (2002) 623-649 vi
22. Thoresen M., and Whitelaw A. Cardiovascular changes during mild therapeutic hypothermia and rewarming in infants with hypoxic-ischemic encephalopathy. Pediatrics 106 1 Pt 1 (2000) 92-99
23. Gunn A.J., Gluckman P.D., Gunn T.R., et al. Selective head cooling in newborn infants after perinatal asphyxia: a safety study. Pediatrics 102 4 Pt 1 (1998) 885-892
24. Eicher D.J., Wagner C.L., Katikaneni L.P., et al. Moderate hypothermia in neonatal encephalopathy: efficacy outcomes. Pediatr Neurol 32 1 (2005) 11-17
25. Shankaran S., Laptook A.R., Ehrenkranz R.A., et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 353 15 (2005) 1574-1584
26. Bona E., Hagberg H., Loberg E.M., et al. Protective effects of moderate hypothermia after neonatal hypoxia-ischemia: short- and long-term outcome. Pediatr Res 43 6 (1998) 738-745
27. Azzopardi D., Robertson N.J., Cowan F.M., et al. Pilot study of treatment with whole body hypothermia for neonatal encephalopathy. Pediatrics 106 4 (2000) 684-694
28. Thoresen M. Cooling the newborn after asphyxia-physiological and experimental background and its clinical use. Semin Neonatol 5 1 (2000) 61-73
29. Shankaran S., Laptook A., Wright L.L., et al. Whole-body hypothermia for neonatal encephalopathy: animal observations as a basis for a randomized, controlled pilot study in term infants. Pediatrics 110 2 Pt 1 (2002) 377-385
30. Battin M.R., Thoresen M., Robinson E., et al. Does head cooling with mild systemic hypothermia affect requirement for blood pressure support?. Pediatrics 123 3 (2009) 1031-1036
31. Groenendaal F., De Vooght K.M., and van Bel F. Blood gas values during hypothermia in asphyxiated term neonates. Pediatrics 123 1 (2009) 170-172
32. Sarkar S., Barks J.D., Bhagat I., et al. Pulmonary dysfunction and therapeutic hypothermia in asphyxiated newborns: whole body versus selective head cooling. Am J Perinatol 26 4 (2009) 265-270
33. Wyatt J.S., Gluckman P.D., Liu P.Y., et al. Determinants of outcomes after head cooling for neonatal encephalopathy. Pediatrics 119 5 (2007) 912-921
34. Laptook A., Tyson J., Shankaran S., et al. Elevated temperature after hypoxic-ischemic encephalopathy: risk factor for adverse outcomes. Pediatrics 122 3 (2008) 491-499
35. Shankaran S., Pappas A., Laptook A.R., et al. Outcomes of safety and effectiveness in a multicenter randomized, controlled trial of whole-body hypothermia for neonatal hypoxic-ischemic encephalopathy. Pediatrics 122 4 (2008) e791-e798
36. Van Leeuwen G.M., Hand J.W., Lagendijk J.J., et al. Numerical modeling of temperature distributions within the neonatal head. Pediatr Res 48 3 (2000) 351-356
37. Robertson N.J., Nakakeeto M., Hagmann C., et al. Therapeutic hypothermia for birth asphyxia in low-resource settings: a pilot randomised controlled trial. Lancet 372 9641 (2008) 801-803
38. Bergeron M., Gidday J.M., Yu A.Y., et al. Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann Neurol 48 3 (2000) 285-296
39. Sheldon R.A., Aminoff A., Lee C.L., et al. Hypoxic preconditioning reverses protection after neonatal hypoxia-ischemia in glutathione peroxidase transgenic murine brain. Pediatr Res 61 6 (2007) 666-670
40. Gidday J.M., Fitzgibbons J.C., Shah A.R., et al. Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neurosci Lett 168 1-2 (1994) 221-224
41. Vannucci R.C., Towfighi J., Vannucci S.J., et al. Hypoxic preconditioning and hypoxic-ischemic brain damage in the immature rat: pathologic and metabolic correlates. J Neurochem 71 3 (1998) 1215-1220
42. Gustavsson M., Anderson M.F., Mallard C., et al. Hypoxic preconditioning confers long-term reduction of brain injury and improvement of neurological ability in immature rats. Pediatr Res 57 2 (2005) 305-309
43. Ran R., Xu H., Lu A., et al. Hypoxia preconditioning in the brain. Dev Neurosci 27 2-4 (2005) 87-92
44. Villa P., Bigini P., Mennini T., et al. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 198 6 (2003) 971-975
45. Wang L., Zhang Z., Wang Y., et al. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35 7 (2004) 1732-1737
46. Chong Z.Z., Kang J.Q., Maiese K., et al. Angiogenesis and plasticity: role of erythropoietin in vascular systems. J Hematother Stem Cell Res 11 6 (2002) 863-871
47. Juul S.E., Yachnis A.T., Rojiani A.M., et al. Immunohistochemical localization of erythropoietin and its receptor in the developing human brain. Pediatr Dev Pathol 2 2 (1999) 148-158
48. Shingo T., Sorokan S.T., Shimazaki T., et al. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci 21 24 (2001) 9733-9743
49. Sola A., Wen T.C., Hamrick S.E., et al. Potential for protection and repair following injury to the developing brain: a role for erythropoietin?. Pediatr Res 57 5 Pt 2 (2005) 110R-117R
50. Kumral A., Uysal N., Tugyan K., et al. Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxia-ischemia in rats. Behav Brain Res 153 1 (2004) 77-86
51. Sola A., Rogido M., Lee B.H., et al. Erythropoietin after focal cerebral ischemia activates the Janus kinase-signal transducer and activator of transcription signaling pathway and improves brain injury in postnatal day 7 rats. Pediatr Res 57 4 (2005) 481-487
52. Chang Y.S., Mu D., Wendland M., et al. Erythropoietin improves functional and histological outcome in neonatal stroke. Pediatr Res 58 1 (2005) 106-111
53. Gonzalez FF, Abel R, Almli CR, et al. Erythropoietin sustains cognitive function and brain volume after neonatal stroke. Dev Neurosci, in press.
54. Wen T.C., Rogido M., Peng H., et al. Gender differences in long-term beneficial effects of erythropoietin given after neonatal stroke in postnatal day-7 rats. Neuroscience 139 3 (2006) 803-811
55. Sun Y., Calvert J.W., and Zhang J.H. Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke 36 8 (2005) 1672-1678
56. Gonzalez F.F., McQuillen P., Mu D., et al. Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke. Dev Neurosci 29 4-5 (2007) 321-330
57. Plane J.M., Liu R., Wang T.W., et al. Neonatal hypoxic-ischemic injury increases forebrain subventricular zone neurogenesis in the mouse. Neurobiol Dis 16 3 (2004) 585-595
58. Lu D., Mahmood A., Qu C., et al. Erythropoietin enhances neurogenesis and restores spatial memory in rats after traumatic brain injury. J Neurotrauma 22 9 (2005) 1011-1017
59. Aher S., and Ohlsson A. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 3 (2006) CD004868
60. Demers E.J., McPherson R.J., Juul S.E., et al. Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia-ischemia. Pediatr Res 58 2 (2005) 297-301
61. McPherson R.J., and Juul S.E. High-dose erythropoietin inhibits apoptosis and stimulates proliferation in neonatal rat intestine. Growth Horm IGF Res 17 5 (2007) 424-430
62. Juul S.E., McPherson R.J., Bauer L.A., et al. A phase I/II trial of high dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety. Pediatrics 122 2 (2008) 504-510
63. Zachary I. Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential. Neurosignals 14 5 (2005) 207-221
64. Palmer T.D., Willhoite A.R., Gage F.H., et al. Vascular niche for adult hippocampal neurogenesis. J Comp Neurol 425 4 (2000) 479-494
65. Krum J.M., and Rosenstein J.M. VEGF mRNA and its receptor flt-1 are expressed in reactive astrocytes following neural grafting and tumor cell implantation in the adult CNS. Exp Neurol 154 1 (1998) 57-65
66. Forstreuter F., Lucius R., Mentlein R., et al. Vascular endothelial growth factor induces chemotaxis and proliferation of microglial cells. J Neuroimmunol 132 1-2 (2002) 93-98
67. Mu D., Jiang X., Sheldon R.A., et al. Regulation of hypoxia-inducible factor 1alpha and induction of vascular endothelial growth factor in a rat neonatal stroke model. Neurobiol Dis 14 3 (2003) 524-534
68. Jin K., Zhu Y., Sun Y., et al. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci U S A 99 18 (2002) 11946-11950
69. Yang X., and Cepko C.L. Flk-1, a receptor for vascular endothelial growth factor (VEGF), is expressed by retinal progenitor cells. J Neurosci 16 19 (1996) 6089-6099
70. Maurer M.H., Tripps W.K., Feldmann Jr. R.E., et al. Expression of vascular endothelial growth factor and its receptors in rat neural stem cells. Neurosci Lett 344 3 (2003) 165-168
71. Bagnard D., Vaillant C., Khuth S.T., et al. Semaphorin 3A-vascular endothelial growth factor-165 balance mediates migration and apoptosis of neural progenitor cells by the recruitment of shared receptor. J Neurosci 21 10 (2001) 3332-3341
72. Raab S., Beck H., Gaumann A., et al. Impaired brain angiogenesis and neuronal apoptosis induced by conditional homozygous inactivation of vascular endothelial growth factor. Thromb Haemost 91 3 (2004) 595-605
73. Zhang Z.G., Zhang L., Jiang Q., et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 106 7 (2000) 829-838
74. Hayashi T., Abe K., Itoyama Y., et al. Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia. J Cereb Blood Flow Metab 18 8 (1998) 887-895
75. Harrigan M.R., Ennis S.R., Sullivan S.E., et al. Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume. Acta Neurochir (Wien) 145 1 (2003) 49-53
76. D'Ercole A.J., Ye P., Calikoglu A.S., et al. The role of the insulin-like growth factors in the central nervous system. Mol Neurobiol 13 3 (1996) 227-255
77. Johnston B.M., Mallard E.C., Williams C.E., et al. Insulin-like growth factor-1 is a potent neuronal rescue agent after hypoxic-ischemic injury in fetal lambs. J Clin Invest 97 2 (1996) 300-308
78. Pang Y., Zheng B., Fan L.W., et al. IGF-1 protects oligodendrocyte progenitors against TNFalpha-induced damage by activation of PI3K/Akt and interruption of the mitochondrial apoptotic pathway. Glia 55 11 (2007) 1099-1107
79. Lin S., Fan L.W., Rhodes P.G., et al. Intranasal administration of IGF-1 attenuates hypoxic-ischemic brain injury in neonatal rats. Exp Neurol 217 2 (2009) 361-370
80. Cheng Y., Gidday J.M., Yan Q., et al. Marked age-dependent neuroprotection by brain-derived neurotrophic factor against neonatal hypoxic-ischemic brain injury. Ann Neurol 41 4 (1997) 521-529
81. Holtzman D.M., Sheldon R.A., Jaffe W., et al. Nerve growth factor protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol 39 1 (1996) 114-122
82. Husson I., Rangon C.M., Lelievre V., et al. BDNF-induced white matter neuroprotection and stage-dependent neuronal survival following a neonatal excitotoxic challenge. Cereb Cortex 15 3 (2005) 250-261
83. Cheng E.T., Utley D.S., Ho P.R., et al. Functional recovery of transected nerves treated with systemic BDNF and CNTF. Microsurgery 18 1 (1998) 35-41
84. Park K.I., Teng Y.D., Snyder E.Y., et al. The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat Biotechnol 20 11 (2002) 1111-1117
85. Hoehn M., Kustermann E., Blunk J., et al. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A 99 25 (2002) 16267-16272
86. Park K.I., Himes B.T., Stieg P.E., et al. Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: evidence from engraftment of Neurotrophin-3-expressing stem cells in hypoxic-ischemic brain injury. Exp Neurol 199 1 (2006) 179-190
87. Park K.I., Hack M.A., Ourednik J., et al. Acute injury directs the migration, proliferation, and differentiation of solid organ stem cells: evidence from the effect of hypoxia-ischemia in the CNS on clonal "reporter" neural stem cells. Exp Neurol 199 1 (2006) 156-178
88. Capone C., Frigerio S., Fumagalli S., et al. Neurosphere-derived cells exert a neuroprotective action by changing the ischemic microenvironment. PLoS One 2 4 (2007) e373
89. Hicks A.U., Hewlett K., Windle V., et al. Enriched environment enhances transplanted subventricular zone stem cell migration and functional recovery after stroke. Neuroscience 146 1 (2007) 31-40
90. Imitola J., Raddassi K., Park K.I., et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A 101 52 (2004) 18117-18122
91. Mueller F.J., Serobyan N., Schraufstatter I.U., et al. Adhesive interactions between human neural stem cells and inflamed human vascular endothelium are mediated by integrins. Stem Cells 24 11 (2006) 2367-2372
92. Modo M., Mellodew K., Cash D., et al. Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study. Neuroimage 21 1 (2004) 311-317
93. Guzman R., Uchida N., Bliss T.M., et al. Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc Natl Acad Sci U S A 104 24 (2007) 10211-10216
94. Rice H.E., Hsu E.W., Sheng H., et al. Superparamagnetic iron oxide labeling and transplantation of adipose-derived stem cells in middle cerebral artery occlusion-injured mice. AJR Am J Roentgenol 188 4 (2007) 1101-1108
95. Obenaus A., Robbins M., Blanco G., et al. Multi-modal magnetic resonance imaging alterations in two rat models of mild neurotrauma. J Neurotrauma 24 7 (2007) 1147-1160
96. Ferriero D.M. Oxidant mechanisms in neonatal hypoxia-ischemia. Dev Neurosci 23 3 (2001) 198-202
97. Fridovich I. Superoxide anion radical (O2-), superoxide dismutases, and related matters. J Biol Chem 272 30 (1997) 18515-18517
98. Halliwell B. Antioxidant defence mechanisms: from the beginning to the end (of the beginning). Free Radic Res 31 4 (1999) 261-272
99. Taylor D.L., Edwards A.D., Mehmet H., et al. Oxidative metabolism, apoptosis and perinatal brain injury. Brain Pathol 9 1 (1999) 93-117
100. Buonocore G., Perrone S., Bracci R., et al. Free radicals and brain damage in the newborn. Biol Neonate 79 3-4 (2001) 180-186
101. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J Neurochem 97 6 (2006) 1634-1658
102. Khan J.Y., and Black S.M. Developmental changes in murine brain antioxidant enzymes. Pediatr Res 54 1 (2003) 77-82
103. Baud O., Li J., Zhang Y., et al. Nitric oxide-induced cell death in developing oligodendrocytes is associated with mitochondrial dysfunction and apoptosis-inducing factor translocation. Eur J Neurosci 20 7 (2004) 1713-1726
104. Volpe J.J. Brain injury in the premature infant. Neuropathology, clinical aspects, pathogenesis, and prevention. Clin Perinatol 24 3 (1997) 567-587
105. Haynes R.L., Baud O., Li J., et al. Oxidative and nitrative injury in periventricular leukomalacia: a review. Brain Pathol 15 3 (2005) 225-233
106. Boucher J.L., Moali C., and Tenu J.P. Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization. Cell Mol Life Sci 55 8-9 (1999) 1015-1028
107. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Phys 271 5 Pt 1 (1996) C1424-C1437
108. Iadecola C., Zhang F., Casey R., et al. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci 17 23 (1997) 9157-9164
109. Higuchi Y., Hattori H., Kume T., et al. Increase in nitric oxide in the hypoxic-ischemic neonatal rat brain and suppression by 7-nitroindazole and aminoguanidine. Eur J Pharmacol 342 1 (1998) 47-49
110. Ishida A., Trescher W.H., Lange M.S., et al. Prolonged suppression of brain nitric oxide synthase activity by 7-nitroindazole protects against cerebral hypoxic-ischemic injury in neonatal rat. Brain Dev 23 5 (2001) 349-354
111. van den Tweel E.R., van Bel F., Kavelaars A., et al. Long-term neuroprotection with 2-iminobiotin, an inhibitor of neuronal and inducible nitric oxide synthase, after cerebral hypoxia-ischemia in neonatal rats. J Cereb Blood Flow Metab 25 1 (2005) 67-74
112. Black S.M., Bedolli M.A., Martinez S., et al. Expression of neuronal nitric oxide synthase corresponds to regions of selective vulnerability to hypoxia-ischaemia in the developing rat brain. Neurobiol Dis 2 3 (1995) 145-155
113. Ferriero D.M., Holtzman D.M., Black S.M., et al. Neonatal mice lacking neuronal nitric oxide synthase are less vulnerable to hypoxic-ischemic injury. Neurobiol Dis 3 1 (1996) 64-71
114. Dawson V.L., Dawson T.M., Bartley D.A., et al. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci 13 6 (1993) 2651-2661
115. Ferriero D.M., Sheldon R.A., Black S.M., et al. Selective destruction of nitric oxide synthase neurons with quisqualate reduces damage after hypoxia-ischemia in the neonatal rat. Pediatr Res 38 6 (1995) 912-918
116. Marks K.A., Mallard C.E., Roberts I., et al. Nitric oxide synthase inhibition attenuates delayed vasodilation and increases injury after cerebral ischemia in fetal sheep. Pediatr Res 40 2 (1996) 185-191
117. Ergenekon E., Gucuyener K., Erbas D., et al. Cerebrospinal fluid and serum nitric oxide levels in asphyxiated newborns. Biol Neonate 76 4 (1999) 200-206
118. Groenendaal F., Vles J., Lammers H., et al. Nitrotyrosine in human neonatal spinal cord after perinatal asphyxia. Neonatology 93 1 (2008) 1-6
119. Schreiber M.D., Gin-Mestan K., Marks J.D., et al. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med 349 22 (2003) 2099-2107
120. Ballard R.A., Truog W.E., Cnaan A., et al. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med 355 4 (2006) 343-353
121. Carloni S., Perrone S., Buonocore G., et al. Melatonin protects from the long-term consequences of a neonatal hypoxic-ischemic brain injury in rats. J Pineal Res 44 2 (2008) 157-164
122. Koh P.O. Melatonin attenuates the focal cerebral ischemic injury by inhibiting the dissociation of pBad from 14-3-3. J Pineal Res 44 1 (2008) 101-106
123. Gitto E., Reiter R.J., Cordaro S.P., et al. Oxidative and inflammatory parameters in respiratory distress syndrome of preterm newborns: beneficial effects of melatonin. Am J Perinatol 21 4 (2004) 209-216
124. Gitto E., Reiter R.J., Sabatino G., et al. Correlation among cytokines, bronchopulmonary dysplasia and modality of ventilation in preterm newborns: improvement with melatonin treatment. J Pineal Res 39 3 (2005) 287-293
125. Palmer C., Towfighi J., Roberts R.L., et al. Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats. Pediatr Res 33 4 Pt 1 (1993) 405-411
126. Clancy R.R., McGaurn S.A., Goin J.E., et al. Allopurinol neurocardiac protection trial in infants undergoing heart surgery using deep hypothermic circulatory arrest. Pediatrics 108 1 (2001) 61-70
127. Benders M.J., Bos A.F., Rademaker C.M., et al. Early postnatal allopurinol does not improve short term outcome after severe birth asphyxia. Arch Dis Child Fetal Neonatal Ed 91 3 (2006) F163-F165
128. Mu D., Chang Y.S., Vexler Z.S., et al. Hypoxia-inducible factor 1alpha and erythropoietin upregulation with deferoxamine salvage after neonatal stroke. Exp Neurol 195 2 (2005) 407-415
129. Hamrick S.E., McQuillen P.S., Jiang X., et al. A role for hypoxia-inducible factor-1alpha in desferoxamine neuroprotection. Neurosci Lett 379 2 (2005) 96-100
130. Almli L.M., Hamrick S.E., Koshy A.A., et al. Multiple pathways of neuroprotection against oxidative stress and excitotoxic injury in immature primary hippocampal neurons. Brain Res Dev Brain Res 132 2 (2001) 121-129
131. Palmer C., Roberts R.L., Bero C., et al. Deferoxamine posttreatment reduces ischemic brain injury in neonatal rats. Stroke 25 5 (1994) 1039-1045
132. Sarco D.P., Becker J., Palmer C., et al. The neuroprotective effect of deferoxamine in the hypoxic-ischemic immature mouse brain. Neurosci Lett 282 1-2 (2000) 113-116
133. Aruoma O.I., Halliwell B., Hoey B.M., et al. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 6 6 (1989) 593-597
134. Paintlia M.K., Paintlia A.S., Barbosa E., et al. N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain. J Neurosci Res 78 3 (2004) 347-361
135. Brion L.P., Bell E.F., Raghuveer T.S., et al. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev 4 (2003) CD003665
136. Olney J.W. Excitotoxicity, apoptosis and neuropsychiatric disorders. Curr Opin Pharmacol 3 1 (2003) 101-109
137. Gucuyener K., Atalay Y., Aral Y.Z., et al. Excitatory amino acids and taurine levels in cerebrospinal fluid of hypoxic ischemic encephalopathy in newborn. Clin Neurol Neurosurg 101 3 (1999) 171-174
138. Kukley M., Capetillo-Zarate E., Dietrich D., et al. Vesicular glutamate release from axons in white matter. Nat Neurosci 10 3 (2007) 311-320
139. Rossi D.J., Oshima T., Attwell D., et al. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 403 6767 (2000) 316-321
140. Fern R., and Moller T. Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop. J Neurosci 20 1 (2000) 34-42
141. Cull-Candy S., Brickley S., Farrant M., et al. NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol 11 3 (2001) 327-335
142. Vannucci S.J., and Hagberg H. Hypoxia-ischemia in the immature brain. J Exp Biol 207 Pt 18 (2004) 3149-3154
143. MacDonald J.F., Jackson M.F., Beazely M.A., et al. Hippocampal long-term synaptic plasticity and signal amplification of NMDA receptors. Crit Rev Neurobiol 18 1-2 (2006) 71-84
144. Deng W., Wang H., Rosenberg P.A., et al. Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress. Proc Natl Acad Sci U S A 101 20 (2004) 7751-7756
145. Salter M.G., and Fern R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 438 7071 (2005) 1167-1171
146. Kinney H.C., and Back S.A. Human oligodendroglial development: relationship to periventricular leukomalacia. Semin Pediatr Neurol 5 3 (1998) 180-189
147. Karadottir R., Cavelier P., Bergersen L.H., et al. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 438 7071 (2005) 1162-1166
148. Ikonomidou C., and Turski L. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?. Lancet Neurol 1 6 (2002) 383-386
149. Chen H.S., and Lipton S.A. The chemical biology of clinically tolerated NMDA receptor antagonists. J Neurochem 97 6 (2006) 1611-1626
150. Chen H.S., Wang Y.F., Rayudu P.V., et al. Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation. Neuroscience 86 4 (1998) 1121-1132
151. Manning S., Talos D., Zhou C., et al. NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia. J Neurosci 28 26 (2008) 6670-6678
152. Volbracht C., van Beek J., Zhu C., et al. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity. Eur J Neurosci 23 10 (2006) 2611-2622
153. Sfaello I., Baud O., Arzimanoglou A., et al. Topiramate prevents excitotoxic damage in the newborn rodent brain. Neurobiol Dis 20 3 (2005) 837-848
154. Noh M.R., Kim S.K., Sun W., et al. Neuroprotective effect of topiramate on hypoxic ischemic brain injury in neonatal rats. Exp Neurol 201 2 (2006) 470-478
155. Klein T.W. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol 5 5 (2005) 400-411
156. Nagayama T., Sinor A.D., Simon R.P., et al. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J Neurosci 19 8 (1999) 2987-2995
157. Panikashvili D., Shein N.A., Mechoulam R., et al. The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of pro-inflammatory cytokines. Neurobiol Dis 22 2 (2006) 257-264
158. Benito C., Romero J.P., Tolon R.M., et al. Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis. J Neurosci 27 9 (2007) 2396-2402
159. Onaivi E.S., Ishiguro H., Gong J.P., et al. Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects. PLoS One 3 2 (2008) e1640
160. van der Stelt M., Veldhuis W.B., van Haaften G.W., et al. Exogenous anandamide protects rat brain against acute neuronal injury in vivo. J Neurosci 21 22 (2001) 8765-8771
161. Fernandez-Lopez D., Pazos M.R., Tolon R.M., et al. The cannabinoid agonist WIN55212 reduces brain damage in an in vivo model of hypoxic-ischemic encephalopathy in newborn rats. Pediatr Res 62 3 (2007) 255-260
162. Turkyilmaz C., Turkyilmaz Z., Atalay Y., et al. Magnesium pre-treatment reduces neuronal apoptosis in newborn rats in hypoxia-ischemia. Brain Res 955 1-2 (2002) 133-137
163. Marret S., Gressens P., Gadisseux J.F., et al. Prevention by magnesium of excitotoxic neuronal death in the developing brain: an animal model for clinical intervention studies. Dev Med Child Neurol 37 6 (1995) 473-484
164. Spandou E., Soubasi V., Papoutsopoulou S., et al. Neuroprotective effect of long-term MgSO4 administration after cerebral hypoxia-ischemia in newborn rats is related to the severity of brain damage. Reprod Sci 14 7 (2007) 667-677
165. Khashaba M.T., Shouman B.O., Shaltout A.A., et al. Excitatory amino acids and magnesium sulfate in neonatal asphyxia. Brain Dev 28 6 (2006) 375-379
166. Crowther C.A., Hiller J.E., Doyle L.W., et al. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA 290 20 (2003) 2669-2676
167. Groenendaal F., Rademaker C.M., Toet M.C., et al. Effects of magnesium sulphate on amplitude-integrated continuous EEG in asphyxiated term neonates. Acta Paediatr 91 10 (2002) 1073-1077
168. Levene M., Blennow M., Whitelaw A., et al. Acute effects of two different doses of magnesium sulphate in infants with birth asphyxia. Arch Dis Child Fetal Neonatal Ed 73 3 (1995) F174-F177
169. Wu Y.W., Escobar G.J., Grether J.K., et al. Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA 290 20 (2003) 2677-2684
170. Wu Y.W., and Colford Jr. J.M. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 284 11 (2000) 1417-1424
171. Dammann O., Kuban K.C., Leviton A., et al. Perinatal infection, fetal inflammatory response, white matter damage, and cognitive limitations in children born preterm. Ment Retard Dev Disabil Res Rev 8 1 (2002) 46-50
172. Stirling D.P., Koochesfahani K.M., Steeves J.D., et al. Minocycline as a neuroprotective agent. Neuroscientist 11 4 (2005) 308-322
173. Dommergues M.A., Patkai J., Renauld J.C., et al. Pro-inflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the newborn murine neopallium. Ann Neurol 47 1 (2000) 54-63
174. Dommergues M.A., Plaisant F., Verney C., et al. Early microglial activation following neonatal excitotoxic brain damage in mice: a potential target for neuroprotection. Neuroscience 121 3 (2003) 619-628
175. Chen M., Ona V.O., Li M., et al. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6 7 (2000) 797-801
176. Zhu S., Stavrovskaya I.G., Drozda M., et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417 6884 (2002) 74-78
177. Pruzanski W., Greenwald R.A., Street I.P., et al. Inhibition of enzymatic activity of phospholipases A2 by minocycline and doxycycline. Biochem Pharmacol 44 6 (1992) 1165-1170
178. Machado L.S., Kozak A., Ergul A., et al. Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke. BMC Neurosci 7 (2006) 56
179. Wang J., Wei Q., Wang C.Y., et al. Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria. J Biol Chem 279 19 (2004) 19948-19954
180. Scarabelli T.M., Stephanou A., Pasini E., et al. Minocycline inhibits caspase activation and reactivation, increases the ratio of XIAP to smac/DIABLO, and reduces the mitochondrial leakage of cytochrome C and smac/DIABLO. J Am Coll Cardiol 43 5 (2004) 865-874
181. Choi Y., Kim H.S., Shin K.Y., et al. Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer's disease models. Neuropsychopharmacology 32 11 (2007) 2393-2404
182. Popovic N., Schubart A., Goetz B.D., et al. Inhibition of autoimmune encephalomyelitis by a tetracycline. Ann Neurol 51 2 (2002) 215-223
183. Du Y., Ma Z., Lin S., et al. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc Natl Acad Sci U S A 98 25 (2001) 14669-14674
184. Yrjanheikki J., Tikka T., Keinanen R., et al. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A 96 23 (1999) 13496-13500
185. Wang C.X., Yang T., Shuaib A., et al. Effects of minocycline alone and in combination with mild hypothermia in embolic stroke. Brain Res 963 1-2 (2003) 327-329
186. Arvin K.L., Han B.H., Du Y., et al. Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol 52 1 (2002) 54-61
187. Fox C., Dingman A., Derugin N., et al. Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion. J Cereb Blood Flow Metab 25 9 (2005) 1138-1149
188. Cai Z., Lin S., Fan L.W., et al. Minocycline alleviates hypoxic-ischemic injury to developing oligodendrocytes in the neonatal rat brain. Neuroscience 137 2 (2006) 425-435
189. Carty M.L., Wixey J.A., Colditz P.B., et al. Post-insult minocycline treatment attenuates hypoxia-ischemia-induced neuroinflammation and white matter injury in the neonatal rat: a comparison of two different dose regimens. Int J Dev Neurosci 26 5 (2008) 477-485
190. Wasserman J.K., Zhu X., Schlichter L.C., et al. Evolution of the inflammatory response in the brain following intracerebral hemorrhage and effects of delayed minocycline treatment. Brain Res 1180 (2007) 140-154
191. Tsuji M., Wilson M.A., Lange M.S., et al. Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model. Exp Neurol 189 1 (2004) 58-65
192. Northington F.J., Ferriero D.M., Graham E.M., et al. Early neurodegeneration after hypoxia-ischemia in neonatal rat is necrosis while delayed neuronal death is apoptosis. Neurobiol Dis 8 2 (2001) 207-219
193. Portera-Cailliau C., Price D.L., Martin L.J., et al. Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: further evidence for an apoptosis-necrosis continuum. J Comp Neurol 378 1 (1997) 88-104
194. Northington F.J., Graham E.M., Martin L.J., et al. Apoptosis in perinatal hypoxic-ischemic brain injury: how important is it and should it be inhibited?. Brain Res Brain Res Rev 50 2 (2005) 244-257
195. Hu B.R., Liu C.L., Ouyang Y., et al. Involvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation. J Cereb Blood Flow Metab 20 9 (2000) 1294-1300
196. Feng Y., Fratkin J.D., LeBlanc M.H., et al. Inhibiting caspase-8 after injury reduces hypoxic-ischemic brain injury in the newborn rat. Eur J Pharmacol 481 2-3 (2003) 169-173
197. Han B.H., Xu D., Choi J., et al. Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury. J Biol Chem 277 33 (2002) 30128-30136
198. Blomgren K., Zhu C., Wang X., et al. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of "pathological apoptosis"?. J Biol Chem 276 13 (2001) 10191-10198
199. Ostwald K., Hagberg H., Andine P., et al. Upregulation of calpain activity in neonatal rat brain after hypoxic-ischemia. Brain Res 630 1-2 (1993) 289-294
200. Kawamura M., Nakajima W., Ishida A., et al. Calpain inhibitor MDL 28170 protects hypoxic-ischemic brain injury in neonatal rats by inhibition of both apoptosis and necrosis. Brain Res 1037 1-2 (2005) 59-69
201. Nunez J., Yang Z., Jiang Y., et al. 17beta-estradiol protects the neonatal brain from hypoxia-ischemia. Exp Neurol 208 2 (2007) 269-276
202. Hagberg H., Wilson M.A., Matsushita H., et al. PARP-1 gene disruption in mice preferentially protects males from perinatal brain injury. J Neurochem 90 5 (2004) 1068-1075
203. Ducrocq S., Benjelloun N., Plotkine M., et al. Poly(ADP-ribose) synthase inhibition reduces ischemic injury and inflammation in neonatal rat brain. J Neurochem 74 6 (2000) 2504-2511
204. Dietrich W.D., Busto R., Alonso O., et al. Intraischemic but not postischemic brain hypothermia protects chronically following global forebrain ischemia in rats. J Cereb Blood Flow Metab 13 4 (1993) 541-549
205. Trescher W.H., Ishiwa S., Johnston M.V., et al. Brief post-hypoxic-ischemic hypothermia markedly delays neonatal brain injury. Brain Dev 19 5 (1997) 326-338
206. Ma J., and Zhang G.Y. Lithium reduced N-methyl-D-aspartate receptor subunit 2A tyrosine phosphorylation and its interactions with Src and Fyn mediated by PSD-95 in rat hippocampus following cerebral ischemia. Neurosci Lett 348 3 (2003) 185-189
207. Dinse A., Fohr K.J., Georgieff M., et al. Xenon reduces glutamate-, AMPA-, and kainate-induced membrane currents in cortical neurones. Br J Anaesth 94 4 (2005) 479-485
208. + channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol 65 2 (2004) 443-452
209. Ma D., Hossain M., Chow A., et al. Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann Neurol 58 2 (2005) 182-193
210. Busto R., Globus M.Y., Dietrich W.D., et al. Effect of mild hypothermia on ischemia-induced release of neurotransmitters and free fatty acids in rat brain. Stroke 20 7 (1989) 904-910
211. Hobbs C., Thoresen M., Tucker A., et al. Xenon and hypothermia combine additively, offering long-term functional and histopathologic neuroprotection after neonatal hypoxia/ischemia. Stroke 39 4 (2008) 1307-1313
212. Khan M., Sekhon B., Jatana M., et al. Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke. J Neurosci Res 76 4 (2004) 519-527
213. Sekhon B., Sekhon C., Khan M., et al. N-Acetyl cysteine protects against injury in a rat model of focal cerebral ischemia. Brain Res 971 1 (2003) 1-8
214. Jatana M., Singh I., Singh A.K., et al. Combination of systemic hypothermia and N-acetylcysteine attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr Res 59 5 (2006) 684-689
215. Alkan T., Kahveci N., Buyukuysal L., et al. Neuroprotective effects of MK 801 and hypothermia used alone and in combination in hypoxic-ischemic brain injury in neonatal rats. Arch Physiol Biochem 109 2 (2001) 135-144
216. Liu Y., Barks J.D., Xu G., et al. Topiramate extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in neonatal rats. Stroke 35 6 (2004) 1460-1465